Navigation Links
Antiviral Drugs Should Be Used Cautiously to Fight Flu, U.S. Says
Date:9/8/2009

influenza need prompt treatment with antiviral medicines," she said. "That can be a very important way to reduce the severity of illness. We don't want providers to wait until test results are available, but we want them to start antivirals when you suspect influenza."

The new guidelines also recommend that, when high-risk people have been in contact with someone who has the H1N1 swine flu, doctors should wait to see if flu symptoms develop before starting treatment with antivirals.

"Instead of starting antivirals, we give providers an option we call 'watchful waiting,' and wait and see if fever develops," Schuchat said. "And, when fever or respiratory problems develop, give antivirals then."

Another key to the best use of antivirals in people at risk for complications is to start the drugs as soon as flu symptoms appear, Schuchat said.

She stressed, however, that the new guidelines leave room for judgment and discretion on the part of doctors. "Every patient is different, and we want clinicians to have that opportunity to customize care for each patient," she said.

The recommendations include:

  • Treatment with antivirals is recommended for people at higher risk for complications. These include children younger than 5 years old, adults 65 and older, pregnant women, people with chronic medical or immunosuppressive conditions, such as patients on chemotherapy, and people younger than 19 years of age who are receiving long-term aspirin therapy.
  • Treatment should not wait for lab tests because testing can delay treatment and a negative rapid test for flu does not rule out influenza.
  • For some high-risk patients, doctors may choose to give them antiviral prescriptions that can be filled should symptoms appear.

Schuchat noted that cases of H1N1 swine flu -- now the predominant flu strain in the United States -- have already started to increase, especially in so
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Antiviral Wont Improve Bells Palsy Outcome
2. Antivirals reduce deaths from flu in hospitalized patients
3. Pharsight Invited to Present on Antiviral Modeling and Simulation at DIA Adherence Workshop
4. Antiviral therapy helps children at risk for post-transplant lymphoproliferative disease
5. Doctor Recommends New Powerful Natural Antiviral Against the Flu
6. Common Flu Strain Resistant to Popular Antiviral Drug
7. eFoodSafety Enters Research Agreement with University of Minnesota to Test New Food-Grade Antiviral for Swine Influenza Virus
8. Liver transplant recipients with hepatitis B may need lifelong antiviral treatment
9. Obio Pharmaceutical Announced New Antiviral Drug Discovery to Combat Influenza Virus
10. Do patients at risk for B-cell malignancy need antiviral treatment?
11. Nuvilex Advances Release of Citroxin(TM) Antiviral Surface Cleaner to Help Combat Swine Flu
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... Wright & Schulte LLC, who is currently representing ... of Syngenta corn lawsuits now pending in ... District of Kansas, have risen sharply since the proceeding ... released by the U.S. Judicial Panel on Multidistrict Litigation ... are now consolidated in the federal litigation, all of ...
(Date:3/30/2015)... York (PRWEB) March 30, 2015 A ... filed in California Superior Court on behalf of a ... birth defect after his mother was prescribed the anti-nausea ... the March 6th filing in Alameda Superior Court, the ... and vomiting that she experienced in the early months ...
(Date:3/30/2015)... On March 11, 2015, Elle Magazine, in an ... six new treatment options for dealing with stubborn, unwanted fat. ... topical product. The other three technologies use devices to deliver ... freezing cold ( CoolSculpting ) to kill fat cells. (see: ... us to permanently remove unwanted fat," says Dr. Simon Ourian, ...
(Date:3/30/2015)... 30, 2015 In a recent report ... Governor Chris Christie is championing effective drug and alcohol ... is scrambling to recover funds to stabilize the addiction ... for victims of drug and alcohol addiction. Harbor Village ... plagued by substance use disorders in New Jersey, in ...
(Date:3/30/2015)... This report studies the global pharmacovigilance and ... of 2014 to 2019. This market is expected ... 2014 to 2019. , Further Inquiry @ ... pharmacovigilance and drug safety software market has been ... functionality, namely, adverse event reporting software, drug safety ...
Breaking Medicine News(10 mins):Health News:Syngenta Corn Lawsuit Claims Continue To Be Filed By Non GMO Corn Farmers Reports Wright & Schulte LLC 2Health News:Syngenta Corn Lawsuit Claims Continue To Be Filed By Non GMO Corn Farmers Reports Wright & Schulte LLC 3Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 2Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 3Health News:New Zofran Lawsuit Alleging Birth Defects Filed This Month in California Superior Court 4Health News:UltraShape and CoolSculpting: Two New Fat-Busting Technologies 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 2Health News:Harbor Village Detox Extends Addiction Treatment to NJ & Suggests 7 Ways to Find the Best Recovery Center 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 2Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 3Health News:The Global Pharmacovigilance and Drug Safety Software Market is Poised to reach the Value of $154.1 Million in 2019 - Report by MarketsandMarkets 4
... BIO International Convention , ... Atlanta, GA (PRWEB) May 31, 2009 -- ... BIO International Convention. The leading hair regeneration company joined more ... largest annual event for the biotechnology industry, held May 18-21 at the ...
... with advanced disease, , , SATURDAY, May 30 (HealthDay News) --A ... study. , Melanoma is the most serious type of skin ... are 65 percent and 16 percent, respectively. In 2009, an ... with melanoma and about 8,600 will die of the disease, ...
... points to estrogen,s potential role in the disease, experts ... current use of combined hormone replacement therapy (HRT) is ... diagnosed with non-small cell lung cancer, a new study ... less high in former smokers and least high in ...
... study presented on Saturday is embargoed until the time ... other studies is not embargoed , CAFFEINE SHOWN AS ... INHALER , An Indiana University study found that the ... reduce the symptoms of exercise induced asthma (EIA). ...
... longer-term study, researchers say , , SATURDAY, May 30 (HealthDay ... lung, breast and metastatic colorectal cancers, appears ineffective for ... trial,s lead author called "disappointing." , "There,s no sense ... drama. We failed to provide patients with a novel ...
... SCOTTSDALE, Ariz., May 30 MedTrust Online LLC simultaneously ... of financing, released a more powerful search engine for ... another world class oncologist to its Advisory Board. ... Online is rapidly becoming the leading source for cancer ...
Cached Medicine News:Health News:Aderans Research BIO International Press Release 2Health News:Aderans Research BIO International Press Release 3Health News:Experts Optimistic About Melanoma Vaccine 2Health News:HRT Ups Death Risk for Women With Lung Cancer 2Health News:HRT Ups Death Risk for Women With Lung Cancer 3Health News:Indiana U. research at the American College of Sports Medicine conference 2Health News:Indiana U. research at the American College of Sports Medicine conference 3Health News:Indiana U. research at the American College of Sports Medicine conference 4Health News:Indiana U. research at the American College of Sports Medicine conference 5Health News:Indiana U. research at the American College of Sports Medicine conference 6Health News:Avastin Shows No Benefit Against Early Stage Colon Cancer 2Health News:Avastin Shows No Benefit Against Early Stage Colon Cancer 3Health News:Avastin Shows No Benefit Against Early Stage Colon Cancer 4Health News:MedTrust Online Completes Second Round of Financing, Releases Next Generation Search Engine for Oncology Utilizing Dell eHealthcare Architecture Framework 2
(Date:3/30/2015)... , March 30, 2015  Building on the momentum ... the leading provider of medical alert systems, has announced aggressive ... Services (HCBS) program and Managed Care business models. ... Texas , Tennessee and ... awarded 16 regional contracts to span statewide coverage in each ...
(Date:3/30/2015)... Research and Markets ( ... the "Urological Catheters - Global Strategic ... This report analyzes the worldwide ... and US$ Thousands by the following Product ... Catheters), and Urinary Catheters (Foley Catheters, Intermittent ...
(Date:3/30/2015)... 30, 2015  Rigrodsky & Long, P.A.: , ... ASPX )? , Did you purchase any of ... you think the proposed buyout price is too low? ... Rigrodsky & Long, P.A. announces that it ... of Auspex Pharmaceuticals, Inc. ("Auspex" or the "Company") (NASDAQ GM: ...
Breaking Medicine Technology:MedScope's Aggressive 2015 Expansion Focuses on Medicaid Waiver and Managed Care Organizations 2Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 2Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 3Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 4Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 5Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 6Urological Catheters - Global Strategic Business Report 2015-2020: Burgeoning Ageing Populace to Propel Catheter Usage 7AUSPEX PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout 2
... 2007 - Array BioPharma Inc.,(Nasdaq: ARRY) today announced that its Chief ... Emerging,Growth Conference on July 10 in New York City. The public ... BioPharma website. -0-, ,Event: ... Robert E. Conway, Chief Executive Officer, Array, ...
... July 03, 2007,/PRNewswire-FirstCall/ -- Rosetta Genomics Ltd , ... French, Rosetta Genomics,President, will present at CE Unterberg, ... at 11:00 am EST at,the Mandarin Oriental Hotel ... of the presentation will be available on,the "Investors" ...
Cached Medicine Technology:Rosetta Genomics to Webcast Presentation at CE Unterberg, Towbin,Emerging Growth Opportunities Conference 2
Headlight module is mounted on UltraLite Plus headband or sweatband....
It is a magnifying headlight perfect for all applications and procedures where clear magnification and a natural white light increase accuracy and productivity....
... is powerful, lightweight, easy ... soft, durable foam silicone ... covered by machine washable ... headband easily adjusts to ...
Solarc surgical headlight is durable, comfortable, lightweight and delivers the bright, white light expected from a xenon system, but at a fraction of the cost....
Medicine Products: